Companies: 10,795·Total market cap: $144.5T
Cellectis S.A.

Cellectis S.A.

CMVLFOTCHealthcare
$3.47
+$0.39(+12.66%)
Market Cap$250969485
P/E Ratio
52W High$5.04
52W Low$1.25
Overview

Cellectis S.A.(CMVLF)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

cmvlf · 股价预测 · 10 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 10 位华尔街分析师

SellBuy

Buy

10 位分析师

共识

评级分布

Strong Buy
0
Buy
7
Hold
2
Sell
1
Strong Sell
0
合计: 10 · 买入占比: 70.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $3.47

Cellectis S.A.(CMVLF)的分析师共识为 Buy,基于过去 3 个月内 10 位华尔街分析师的评级。CMVLF 的 12 个月平均目标价为 $0.00,相对当前价 $3.47 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$3.634.59%

1-day model range: $3.61–$3.64. Peak: $3.64 (+4.59%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

64%15%21%
9Buy
2Neutral
3Sell
RSI (14)100.0Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · CMVLF · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$3.39BUY
MA 10$3.24BUY
MA 20$3.16BUY
MA 50$3.27BUY
MA 100$3.83SELL
MA 200$0.00NEUTRAL
Current $CMVLF · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$3.39BUY
EMA 10$3.30BUY
EMA 20$3.22BUY
EMA 50$3.37BUY
EMA 100$3.71SELL
EMA 200$0.00NEUTRAL
Current $CMVLF · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Oppenheimer2023-08-07
Maintains
OutperformOutperform
JMP Securities2023-08-06
Maintains
Market OutperformMarket Outperform
Citigroup2023-04-04
Maintains
BuyBuy
Oppenheimer2023-03-12
Maintains
OutperformOutperform
JMP Securities2023-01-18
Maintains
Market OutperformMarket Outperform
Goldman Sachs2022-05-23
Maintains
SellSell
Baird2022-05-17
Upgrade ↑
NeutralOutperform
Barclays2022-05-12
Maintains
OverweightOverweight
Wells Fargo2022-01-05
Downgrade ↓
OverweightEqual Weight
Baird2021-10-07
Downgrade ↓
OutperformNeutral

Wall Street analysts have recently issued updated ratings on Cellectis S.A. (CMVLF) stock. Of the recent 19 rating actions, 3 were upgrades and 5 were downgrades. 10 analysts currently cover CMVLF.

分析师推荐趋势

Buy ratings02↑ +2
Hold ratings101
Sell ratings00

CMVLF analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$60M

↓ 16.8% YoY

Revenue Next Year

$116M

↑ 93.1% YoY

EPS This Year

$-0.91

EPS Next Year

$-0.73

↓ 19.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CMVLF EPS of $-0.91 for the current fiscal year, based on estimates from 1 analysts. The CMVLF revenue forecast is $60M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CMVLF 股价预测由两类独立数据源支撑:来自 10 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。CMVLF 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

CMVLF 的短期预测(明日)为 $3.63(+4.59%)。

Cellectis S.A. 在 OTC 上市,代码 CMVLF。CMVLF 在 2027 年的整体展望偏积极,在覆盖分析师中约 70% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

CMVLF 预测 · 8 个问题

根据 10 位华尔街分析师,CMVLF 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $3.47,隐含约 +0.0% 的上行空间。

CMVLF 目标价CMVLF 分析师目标价CMVLF 12个月目标价目标价 CMVLF

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.